Candidate Drug designated within the Medivir Tibotec Collaboration
02-Jan-2006
Separately, the first milestone for preclinical development has been reached in the program, triggering a milestone payment to Medivir of EUR5m.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.